# Affect of Duavive on Mood & Anxiety Symptoms

> **NCT04478305** · PHASE1 · RECRUITING · sponsor: **St. Joseph's Healthcare Hamilton** · enrollment: 30 (estimated)

## Conditions studied

- Menopause
- Depression, Anxiety
- Sleep
- Menopause Related Conditions

## Interventions

- **DRUG:** Duavive 0.45Mg-20Mg Tablet

## Key facts

- **NCT ID:** NCT04478305
- **Lead sponsor:** St. Joseph's Healthcare Hamilton
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-07-03
- **Primary completion:** 2025-12
- **Final completion:** 2025-12
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2024-12-03

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04478305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04478305, "Affect of Duavive on Mood & Anxiety Symptoms". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04478305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*